menu

Overcoming sAML Therapeutic and Clinical Challenges

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Overcoming sAML Therapeutic and Clinical Challenges

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    With current limitations of some of the therapies used for secondary acute myeloid leukemia (sAML), this is also contributing to the unmet needs of patients. So new therapies in development are essential for optimizing patient care to those with sAML. To learn more about the therapeutic and clinical challenges of sAML, join Dr. Charles Turck as he speaks with Dr. Sanam Loghavi, Assistant Professor in the Department of Hematopathology in the Division of Pathology Lab Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Curtis Lachowiez, Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at the Oregon Health and Science University.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    With current limitations of some of the therapies used for secondary acute myeloid leukemia (sAML), this is also contributing to the unmet needs of patients. So new therapies in development are essential for optimizing patient care to those with sAML. To learn more about the therapeutic and clinical challenges of sAML, join Dr. Charles Turck as he speaks with Dr. Sanam Loghavi, Assistant Professor in the Department of Hematopathology in the Division of Pathology Lab Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Curtis Lachowiez, Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at the Oregon Health and Science University.

Facebook Comments

Schedule19 Jun 2024